Document de presse
2021.01.19
Scientists from the Institut Pasteur-TheraVectys Joint Laboratory recently published in Cell Host & Microbe1 the results of tests, in two preclinical...
Document de presse
2020.04.24
Approximately four months after the initial description of cases of atypical pneumonia in Wuhan, China, in December 2019, COVID-19 had become a major pandemic...
Document de presse
2020.08.12
Since the late 1990s, immunotherapy has been the frontline treatment against lymphomas where synthetic antibodies are used to stop the proliferation of...
News
2020.07.24
A new endogenous viral element (EVE) has been identified in Aedes aegypti mosquitoes. This EVE is almost identical to a contemporaneous strain of cell-fusing...
Document de presse
2020.07.15
Which patients will develop a severe form of Covid-19? This is a key question that needs to be answered to improve the individual management and prognosis of...
Document de presse
2020.07.06
Every winter, seasonal coronaviruses are responsible for repeated colds and bronchitis from early childhood onwards. The question of whether the four seasonal...
News
2020.07.07
Aptamers are DNA or RNA molecules that can bind with high affinity and/or specificity to target molecules. Given their properties, aptamers offer numerous...
Document de presse
2020.06.23
In late April 2020, scientists at the Institut Pasteur, with the support of the Hauts-de-France Regional Health Agency and the Amiens Education Authority,...
News
2020.06.22
Alzheimer's and Parkinson's diseases are the most widespread forms of neurodegeneration in humans. Each year, 225,000 new cases of Alzheimer's disease are...
News
2020.01.22
Dans le cadre de sa mission de surveillance des virus respiratoires sur le territoire français, l’Institut Pasteur mobilise ses équipes, notamment via le...